HOW BIOTECH & PHARMA COMPANIES USE ANALYTICS TO …

https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences-outlook.pdf

https://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069962.htm

https://www.zs.com/about/news-and-events/as-doctors-keep-closing-doors-on-pharma-reps.aspx

SOLUTIONSPROBLEMS

MicroStrategy mobile apps help commercial

sales reps tailor their interactions with physicians

so they can make the most e�ective use of

limited meeting times.

MicroStrategy solutions help pharma executives

optimize their supply chain, marketing, and sales

operations in order to maximize the returns on new

product o�erings.

MicroStrategy security solutions help life

sciences companies protect intellectual property and

sensitive clinical data using sophisticated physical and

logical access controls.

MicroStrategy helps drug companies monitor

and analyze their complex global distribution networks

to surface hidden performance issues and uncover

potential counterfeiting situations.

MicroStrategy helps marketing executives

gauge the e�ectiveness of advertising campaigns

by analyzing their in�uence on drug purchases and

prescription renewals.

TASKS

EXECUTIVEDASHBOARD

MARKETINGPERFORMANCE

DIGITALEMPLOYEE

BADGE

DISTRIBUTIONANALYSIS

FIELD SALESENABLEMENT

Leading biotech and pharmaceutical companies rely on MicroStrategy solutions to bring new products to market faster and to maximize the return on their development investments. Learn more at microstrategy.com/solutions/biotechandpharma

Operating in intensely competitive global markets, life sciences companies need powerful analytical

solutions to accelerate drug development and optimize marketing and sales activities.

HOW BIOTECH & PHARMA COMPANIES USE ANALYTICS TO BRINGINSIGHT AND EFFICIENCY TO EVERY ASPECT OF THEIR VALUE CHAINS

https://www.statnews.com/2016/03/09/drug-industry-advertising/

IN THE US, PHARMA COMPANIES

RECEIVE A

5-YEAR PERIODOF

MARKET EXCLUSIVITY FOR NEWLY APPROVED

DRUGS

Drug makers spent$5.2 BILLION

on TV and print advertising in 2015

In 2011, the UK’s life sciences and

health care industry su�ered

$2.9 billion in losses due

to IP theft.

http://trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf

The size of the global counterfeit drug market is estimated to be as high as $200 billion, and can make up

of all drugs sold in some countries.

44% of physicians are considered “accessible” to sales reps.

Based on a 2016 study, just

1/2